Telisotuzumab (ABT-700) is a human recombinant bivalent антитело, a therapeutic антитело against the hepatocyte growth factor рецептор (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity.
Telisotuzumab (ABT-700) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.